RUNX2 Antikörper
-
- Target Alle RUNX2 Antikörper anzeigen
- RUNX2 (Runt-Related Transcription Factor 2 (RUNX2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RUNX2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthesized peptide derived from the Internal region of human RUNX2.
- Isotyp
- IgG
- Top Product
- Discover our top product RUNX2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IF 1:50-1:200, ELISA 1:20000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 0.5 % BSA and 50 % glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- RUNX2 (Runt-Related Transcription Factor 2 (RUNX2))
- Andere Bezeichnung
- RUNX2 (RUNX2 Produkte)
- Hintergrund
- Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters (By similarity). Inhibits MYST4-dependent transcriptional activation.
- Molekulargewicht
-
Observed_MW: 56 kDa
Calculated_MW: 57 kDa
- UniProt
- Q13950
-